Follow
Mark S. Sands
Title
Cited by
Cited by
Year
AAV vector integration sites in mouse hepatocellular carcinoma
A Donsante, DG Miller, Y Li, C Vogler, EM Brunt, DW Russell, MS Sands
Science 317 (5837), 477-477, 2007
7222007
Gene therapy for lysosomal storage diseases
MS Sands, BL Davidson
Molecular Therapy 13 (5), 839-849, 2006
3462006
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors
A Donsante, C Vogler, N Muzyczka, JM Crawford, J Barker, T Flotte, ...
Gene therapy 8 (17), 1343-1346, 2001
3432001
Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells
MA Young, DE Larson, CW Sun, DR George, L Ding, CA Miller, L Lin, ...
Cell stem cell 10 (5), 570-582, 2012
2572012
Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer
JH Wolfe, MS Sands, JE Barker, B Gwynn, LB Rowe, CA Vogler, ...
Nature 360 (6406), 749-753, 1992
2461992
In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models
TE Meyerrose, DA De Ugarte, AA Hofling, PE Herrbrich, TD Cordonnier, ...
Stem cells 25 (1), 220-227, 2007
2342007
Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease
TM Daly, C Vogler, B Levy, ME Haskins, MS Sands
Proceedings of the National Academy of Sciences 96 (5), 2296-2300, 1999
2341999
Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
MS Sands, C Vogler, JW Kyle, JH Grubb, B Levy, N Galvin, WS Sly, ...
The Journal of clinical investigation 93 (6), 2324-2331, 1994
2281994
CMV-β-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1α promoter and results in …
L Xu, T Daly, C Gao, TR Flotte, S Song, BJ Byrne, MS Sands, KP Ponder
Human gene therapy 12 (5), 563-573, 2001
2142001
Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo
H Kitaura, MS Sands, K Aya, P Zhou, T Hirayama, B Uthgenannt, S Wei, ...
The Journal of Immunology 173 (8), 4838-4846, 2004
2112004
Recombinant adeno-associated viral integration and genotoxicity: insights from animal models
RJ Chandler, MS Sands, CP Venditti
Human gene therapy 28 (4), 314-322, 2017
2042017
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis
C Kielar, L Maddox, E Bible, CC Pontikis, SL Macauley, MA Griffey, ...
Neurobiology of disease 25 (1), 150-162, 2007
1862007
Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
MS Sands, JE Barker, C Vogler, B Levy, B Gwynn, N Galvin, WS Sly, ...
Laboratory investigation; a journal of technical methods and pathology 68 (6 …, 1993
1831993
Clinical course of sly syndrome (mucopolysaccharidosis type VII)
AM Montaño, N Lock-Hock, RD Steiner, BH Graham, M Szlago, ...
Journal of medical genetics 53 (6), 403-418, 2016
1802016
Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning
BJ Kolber, MS Roberts, MP Howell, DF Wozniak, MS Sands, LJ Muglia
Proceedings of the National Academy of Sciences 105 (33), 12004-12009, 2008
1702008
CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis
MA Griffey, D Wozniak, M Wong, E Bible, K Johnson, SM Rothman, ...
Molecular Therapy 13 (3), 538-547, 2006
1602006
VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients
PP Young, AA Hofling, MS Sands
Proceedings of the National Academy of Sciences 99 (18), 11951-11956, 2002
1572002
Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking
JR Zhang, T Coleman, SJ Langmade, DE Scherrer, L Lane, MH Lanier, ...
The Journal of clinical investigation 118 (6), 2281-2290, 2008
1542008
Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer
TM Daly, KK Ohlemiller, MS Roberts, CA Vogler, MS Sands
Gene therapy 8 (17), 1291-1298, 2001
1462001
Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.
MS Sands, C Vogler, A Torrey, B Levy, B Gwynn, J Grubb, WS Sly, ...
The Journal of clinical investigation 99 (7), 1596-1605, 1997
1461997
The system can't perform the operation now. Try again later.
Articles 1–20